Skip to content
Future from a16z

A new site for understanding the future, how tech shapes it, and how we build it.

Go to Future
It's time to build
Nav Opener
  • Portfolio
  • Team
  • Focus Areas
    • American Dynamism
    • Bio + Health
    • Cultural Leadership Fund
    • Consumer
    • Crypto
    • Enterprise
    • Fintech
    • Games
    • Growth
    • Talent x Opportunity
  • Content
    Topics
    • Fintech
    • Gaming & Social
    • Security & Privacy
    • Marketplaces
    • Enterprise & SaaS
    • Bio + Health
    • Creator Economy
    • Cryptocurrencies & Blockchains
    Type
    • Articles
    • Video
    • Podcasts
    • Newsletters
  • About
  • Jobs
Close

Vijay Pande

Vijay Pande Download Photo Twitter LinkedIn

Vijay Pande, PhD, is a general partner at Andreessen Horowitz, where he focuses on investments in biopharma and healthcare. As the founding investor of a16z’s Bio Fund, Vijay leads the firm’s investments at the cross section of biology and computer science, including applications in computation, machine learning, and artificial intelligence in healthcare; digital therapeutics; diagnostics; and other novel transformative scientific advances applied to industry that take bio beyond healthcare. Op-eds by Vijay defining trends and issues in this emerging space have been published by The New York Times, Scientific American, and Forbes, among others. He is also an Adjunct Professor of Bioengineering at Stanford University.

Previously, Vijay was the Henry Dreyfus Professor of Chemistry and Professor of Structural Biology and of Computer Science at Stanford University, where he led a team of researchers pioneering computational methods and their application to medicine and biology (resulting in over 300 publications, two patents, and two novel drug candidates). Vijay was also concurrently the director of the Biophysics program at Stanford, where he led a team of more than 50 faculty members and propelled the program to the top in the country.

During his time at Stanford, Vijay co-founded Globavir Biosciences, where he translated his research advances into a successful startup that aimed to discover cures for Dengue Fever and Ebola. Vijay also founded the [email protected] Distributed Computing Project for disease research, which pushed the boundaries of computer science techniques (distributed systems, machine learning, and exotic computer architectures) into biology and medicine, in both research as well as the development of new therapeutics.

Vijay holds a BA in Physics from Princeton University and a PhD in Physics from MIT. He has been awarded the DeLano Prize in Computation; a Guinness World Record for [email protected]; the American Chemical Society Thomas Kuhn Paradigm Shift Award; and was selected for MIT TR10. In his teens, Vijay was the first employee at video game startup Naughty Dog Software, maker of Crash Bandicoot.

Pande serves on the boards of Apeel Sciences, BioAge, Devoted Health, Freenome, Insitro, Nobell, Omada Health, Q.bio, and Scribe Therapeutics.

Latest Posts

New Year, New Fund, New Opportunities in Bio + Health

by Vineeta Agarwala, Jorge Conde, Justin Larkin, Vijay Pande, Becky Pferdehirt, Jay Rughani, Judy Savitskaya, Daisy Wolf, and Julie Yoo
  • bio + health
  • announcements
  • gene editing including CRISPR
  • healthcare
  • therapeutics
  • when science becomes engineering

The Coming Age for Tech x Bio: The ‘Industrial Bio Complex’

by Vijay Pande
  • bio + health
  • how innovation happens

a16z Podcast: Uncontrolled Spread: Science, Policy, Institutions, Infrastructure

by Scott Gottlieb, Vineeta Agarwala, Marc Andreessen, and Vijay Pande
  • bio + health
  • policy & regulation
  • book launches (and book pods)
  • coronavirus & the COVID-19 pandemic
  • supply chains, logistics, and infrastructure
  • vaccines

16 Minutes #67: mRNA for Flu Vaccine; AI Protein-Folding Goes Open Source

by Vineeta Agarwala, Jorge Conde, Vijay Pande, and Zoran Basich
  • AI, machine & deep learning
  • bio + health
  • open source
  • 16 Minutes
  • protein folding
  • vaccines
  • when science becomes engineering

From @vijaypande

Vijay Pande@vijaypande

Very excited about this one -- @a16z games fund! Congrats @andrewchen , @Tocelot , @gwertz . I can see this additionally connecting to what we do at a16z biohealth, with many interesting companies at the intersection of games & biohealth. https://t.co/eAqD3RzvGE

a16z@a16z

Nurturing and accelerating bio and healthtech breakthroughs is challenging. @vintweeta, @julesyoo, @JorgeCondeBio, @vijaypande and our entire Bio + Health team continue to push the frontier of what is possible. Learn more in @endpts's latest feature: https://t.co/QFgPEpHuDN https://t.co/VX4DP4Jm4Z

Vineeta Agarwala@vintweeta

Great @endpts piece covering the origin story of @a16z bio — and the many exciting opportunities that we continue to see at the intersection of engineering, computation, and biology! https://t.co/XzSfOojXeS

Software is eating the world
© 2022 Andreessen Horowitz
Software is eating the world
    • Twitter
    • Simplecast
  • Contact
  • Jobs
  • Briefings
  • Terms of Use & Privacy
  • Disclosures
  • Conduct
  • Who We Are